|
|
|
| June 2000, Volume 7, Number 11, Pages 960-966 |
| Table of contents Previous Abstract Next Full text PDF |
 |
| Acquired diseases |
| Pretreatment with cationic lipid-mediated transfer of the Na+K+-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedema |
 |
| M Stern1, K Ulrich1, C Robinson1, J Copeland1, U Griesenbach1, C Masse2, S Cheng3, F Munkonge1, D Geddes1, Y Berthiaume2 and E Alton1 |
 |
1Department of Gene Therapy, Imperial College at the National Heart and Lung Institute, London, UK
2Centre de Recherche, Hôtel-Dieu de Montréal and Department of Medicine, Université de Montréal, Montreal, Quebec, Canada
3Genzyme Corporation, Framingham, MA, USA
|
 |
Correspondence to: M Stern, Department of Gene Therapy, National Heart and Lung Institute, Manresa Road, London SW3 6LR, UK
|
 |
| Abstract |
 | Resolution of pulmonary oedema is mediated by active absorption of liquid across the alveolar epithelium. A key component of this process is the sodium-potassium ATPase (Na+K+-ATPase) enzyme located on the basolateral surface of epithelial cells and up-regulated during oedema resolution. We hypothesised that lung liquid clearance could be further up-regulated by lipid-mediated transfer and expression of exogenous Na+K+-ATPase cDNA. We demonstrate proof of this principle in a model of high permeability pulmonary oedema induced by intraperitoneal injection of thiourea (2.5 mg/kg) in C57/BL6 mice. Pretreatment of mice (24 h before thiourea) by nasal sniffing of cationic liposome (lipid #67)-DNA complexes encoding the and subunits of Na+K+-ATPase (160 g per mouse), significantly (P < 0.01) decreased the wet:dry weight ratios measured 2 h after thiourea injection compared with control animals, pretreated with an equivalent dose of an irrelevant gene. whole lung na+K+-ATPase activity was significantly (P < 0.05) increased in mice pretreated with na+K+-ATPase cDNA compared both with untreated control animals as well as animals pretreated with the irrelevant gene. Nested RT-PCR on whole lung homogenates confirmed gene transfer by detection of vector-specific mRNA in three of four mice studied 24 h after gene transfer. This demonstration of a significant reduction in pulmonary oedema following in vivo gene transfer raises the possibility of gene therapy as a novel, localised approach for pulmonary oedema in clinical settings such as ARDS and lung transplantation. Gene Therapy (2000) 7, 960-966. |
 |
| Keywords |
 | gene therapy; Na+K+-ATPase; liposome; pulmonary oedema |
|
 |
 |
 |
| Received 8 November 1999; accepted 28 February 2000 |
 |
| June 2000, Volume 7, Number 11, Pages 960-966 |
| Table of contents Previous Abstract Next Full text PDF |
|
|